RaQualia Pharma Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	3,496	3,340	3,714	3,675	2,345	1,394
Short-Term Investments	47.58	1	49	250	313	719
Cash & Short-Term Investments	3,543	3,341	3,763	3,925	2,658	2,113
Cash Growth	10.71%	-11.21%	-4.13%	47.67%	25.79%	-3.96%
Receivables	549.26	689	603	602	1,205	530
Inventory	184.83	167	147	8	10	6
Prepaid Expenses	234.43	193	188	108	90	50
Other Current Assets	127.85	148	255	179	40	135
Total Current Assets	4,640	4,538	4,956	4,822	4,003	2,834
Property, Plant & Equipment	480.22	529	573	391	299	332
Long-Term Investments	536.81	607	1,306	1,020	897	1,049
Goodwill	3,698	3,865	-	-	-	-
Other Intangible Assets	35.63	37	30	24	33	33
Long-Term Deferred Tax Assets	73.24	78	5	-	-	2
Other Long-Term Assets	55.16	1	1	-	2	1
Total Assets	9,519	9,655	6,871	6,257	5,234	4,251
Accounts Payable	58.26	59	54	128	45	42
Accrued Expenses	65.04	69	54	60	63	49
Current Portion of Long-Term Debt	512.62	512	12	2	-	-
Current Portion of Leases	76.47	69	64	42	21	18
Current Income Taxes Payable	36.92	221	178	237	230	73
Other Current Liabilities	245.99	257	27	24	41	4
Total Current Liabilities	995.3	1,187	389	493	400	186
Long-Term Debt	2,267	2,651	39	9	-	-
Long-Term Leases	193.38	218	251	167	17	27
Long-Term Deferred Tax Liabilities	-	-	-	2	16	14
Other Long-Term Liabilities	20.49	28	73	89	15	15
Total Liabilities	3,476	4,084	752	760	448	242
Common Stock	3,241	2,720	2,667	2,265	2,256	2,255
Additional Paid-In Capital	3,430	2,910	2,857	2,455	2,446	2,445
Retained Earnings	-614.66	-45	449	773	49	-706
Comprehensive Income & Other	-13.82	-14	146	4	35	15
Shareholders' Equity	6,042	5,571	6,119	5,497	4,786	4,009
Total Liabilities & Equity	9,519	9,655	6,871	6,257	5,234	4,251
Total Debt	3,049	3,450	366	220	38	45
Net Cash (Debt)	493.79	-109	3,397	3,705	2,620	2,068
Net Cash Growth	-	-	-8.31%	41.41%	26.69%	-5.96%
Net Cash Per Share	21.48	-5.04	157.22	176.57	124.93	98.71
Filing Date Shares Outstanding	24.46	21.84	21.62	21.6	20.96	20.95
Total Common Shares Outstanding	24.46	21.84	21.62	20.98	20.95	20.95
Working Capital	3,644	3,351	4,567	4,329	3,603	2,648
Book Value Per Share	247.06	255.10	282.98	262.05	228.43	191.35
Tangible Book Value	2,309	1,669	6,089	5,473	4,753	3,976
Tangible Book Value Per Share	94.40	76.43	281.60	260.90	226.86	189.77

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.